Feliz Año Nuevo – Felice Anno Nuovo – Happy New Year…!!!

Esta vez no hay cursos, conferencias, artículos científicos ni llamados a congresos médicos. Sencillamente gracias a todos aquellos que han visitado mi página en estos primeros meses de vida. Desde donde quiera que estén, desde donde viva cada uno de ustedes, sean de la religión que sean, del color de piel que sean, del regimen…

Curso Internacional de Postgrado y XXIV Congreso Mundial – International Postgraduate Course and XXIV World Congress ISSVD.

Próxima Participación: La Sociedad Internacional para el Estudio de la Enfermedad Vulvovaginal (ISSVD = The International Society for the Study of Vulvovaginal Disease) anuncia la realización en la Ciudad de Mendoza, Argentina, del Curso Internacional de Postgrado los días 11 y 12 de septiembre de 2017 seguido por la realización del XXIV Congreso Internacional del…

Vulvovaginal Disease Update 2017.

March 17, 2017. Held at: Baylor College of Medicine, Texas Children’s Hospital Pavilion for Women, Houston, TX. Texas Children’s Pavilion for Women 6651 Main St. Houston, TX 77030 Co-Sponsored by: The North American Chapter of The International Society for the Study of Vulvovaginal Disease & The Vulvovaginal Health Clinic Baylor College of Medicine at Texas Children’s…

Advanced Soft Tissue Sarcoma: Current and Future CME.

Activity Evaluation from Medscape Education. WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest. Robin L. Jones, BSc, MB BS, MRCP, MD: Consultant Medical Oncologist;…

Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms.

Paul Michael Jones and Ronny Drapkin. Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA. Recent developments in the study of epithelial ovarian cancer have called into question the traditional views regarding the site of tumor initiation. Histopathologic studies and genomic analyses suggest that extra-ovarian sites, like the fallopian tube, may…

The fallopian tube as the origin of non-uterine pelvic high-grade serous carcinoma.

Ieera Madan Aggarwal, Yu Hui Lim, Timothy Yong Kuei Lim. Abstract. Key content: Advances in histopathology, immunohistochemistry and molecular genetics have led to evidence that the fimbrial end of the fallopian tube may be the source of origin of non-uterine high-grade pelvic serous carcinoma (HGPSC). Most of the evidence comes from studies in risk-reducing salpingo-oophorectomy…

The management of endometrial polyps in the 21st century.

Annan JJ, Aquilina J, Ball E. The management of endometrial polyps in the 21st century. The Obstetrician & Gynaecologist 2012;14:33–38. Abstract. Key content: Hysteroscopic endometrial polyp removal appears to be superior to the current practice of blind avulsion. Outpatient treatment is safe, cost effective and well tolerated, even in older or nulliparous women. New technologies…

Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.

Willemijne A M E Schrijver, Petra van der Groep, Laurien DC Hoefnagel, Natalie D ter Hoeve, Ton Peeters, Cathy B Moelans and Paul J van Diest.   Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands. Abstract: Distant breast cancer metastases are nowadays routinely biopsied to reassess receptor status and to isolate…

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.

Bradley B Bryan, Stuart J Schnitt and Laura C Collins. Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. Abstract: Basal-like carcinomas have recently been identified in gene expression profiling studies as a subtype of invasive breast cancer. These lesions are estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative (triple negative), and…